Hochschulschrift
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy : A Systematic Review and Meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.1055/s-0042-1758653
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2023
- Creator
- DOI
-
10.18154/RWTH-2023-09043
- URN
-
urn:nbn:de:101:1-2408020133340.201687795510
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Puchstein, Dorothea Katharina
- Kork, Felix
- Schöchl, Herbert
- Rayatdoost, Farahnaz
- Grottke, Oliver
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2023
Other Objects (12)
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Recombinant Factor VIII Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates
Human Factor VIII Concentrates in Hemophiliac Dogs
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Recombinant Factor VIII Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates
Human Factor VIII Concentrates in Hemophiliac Dogs
3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Recombinant Factor VIII Concentrates
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Clinical Use of Factor IX Concentrates
Particulate Material in Factor VIII Concentrates
Degradation of Factor VIII-Related Protein in Factor VIII Concentrates
Heterogeneity of Factor IX in Therapeutic Concentrates